1. Zhang, Y, Corapi, KM, Luongo, M, Thadhani, R, Nigwekar, SU. Calciphylaxis in peritoneal dialysis patients: a single center cohort study. Int J Nephrol Renovasc Dis. 2016;9:235-241.
Google Scholar | Crossref | Medline2. Brandenburg, VM, Kramann, R, Rothe, H, et al. Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry. Nephrol Dial Transplant. 2017;32(1):126-132. doi:10.1093/ndt/gfv438.
Google Scholar | Crossref | Medline3. Nigwekar, SU, Solid, CA, Ankers, E, et al. Quantifying a rare disease in administrative data: the example of calciphylaxis. J Gen Intern Med. 2014;29(suppl 3):S724-S731. doi:10.1007/s11606-014-2910-1.
Google Scholar | Crossref | Medline4. McCarthy, JT, El-Azhary, RA, Patzelt, MT, et al. Survival, risk factors, and effect of treatment in 101 patients with calciphylaxis. Mayo Clin Proc. 2016;91(10):1384-1394. doi:10.1016/j.mayocp.2016.06.025.
Google Scholar | Crossref | Medline5. Selye, H, Gentile, G, Prioreschi, P. Cutaneous molt induced by calciphylaxis in the rat. Science. 1961;134(3493):1876-1877. doi:10.1126/science.134.3493.1876.
Google Scholar | Crossref | Medline6. New, N, Mohandas, J, John, GT, et al. Calcific uremic arteriolopathy in peritoneal dialysis populations. Int J Nephrol. 2011;2011:982854.
Google Scholar | Crossref | Medline7. Fine, A, Zacharias, J. Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int. 2002;61(6):2210-2217. doi:10.1046/j.1523-1755.2002.00375.x.
Google Scholar | Crossref | Medline | ISI8. Weenig, RH, Sewell, LD, Davis, MD, McCarthy, JT, Pittelkow, MR. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol. 2007;56(4):569-579. doi:10.1016/j.jaad.2006.08.065.
Google Scholar | Crossref | Medline9. Nigwekar, SU, Kroshinsky, D, Nazarian, RM, et al. Calciphylaxis: risk factors, diagnosis, and treatment. Am J Kidney Dis. 2015;66:133-146.
Google Scholar | Crossref | Medline | ISI10. Mandelbrot, DA, Santos, PW, Burt, RK, et al. Resolution of SLE-related soft-tissue calcification following haematopoietic stem cell transplantation. Nephrol Dial Transplant. 2008;23:2679-2684.
Google Scholar | Crossref | Medline | ISI11. Slough, S, Servilla, KS, Harford, AM, Konstantinov, KN, Harris, A, Tzamaloukas, AH. Association between calciphylaxis and inflammation in two patients on chronic dialysis. Adv Perit Dial. 2006;22:171-174.
Google Scholar | Medline12. Nigwekar, SU, Zhao, S, Wenger, J, et al. A nationally representative study of calcific uremic arteriolopathy risk factors. J Am Soc Nephrol. 2016;27(11):3421-3429. doi:10.1681/ASN.2015091065.
Google Scholar | Crossref | Medline13. Angelis, M, Wong, LL, Myers, SA, Wong, LM. Calciphylaxis in patients on hemodialysis: a prevalence study. Surgery. 1997;122(6):1083-1089; discussion 1089-1090. doi:10.1016/s0039-6060(97)90212-9.
Google Scholar | Crossref | Medline | ISI14. Bleyer, AJ, Choi, M, Igwemezie, B, de la Torre, E, White, WL. A case control study of proximal calciphylaxis. Am J Kidney Dis. 1998;32(3):376-383. doi:10.1053/ajkd. 1998.v32.pm9740152.
Google Scholar | Crossref | Medline15. Adapa, S, Naramala, S, Gayam, V, et al. Calciphylaxis in a patient on home hemodialysis. J Investig Med High Impact Case Rep. 2020;8:2324709620922718.
Google Scholar | SAGE Journals16. Brewster, UC. Dermatological disease in patients with CKD. Am J Kidney Dis. 2008;51(2):331-44. doi: 10.1053/j.ajkd.2007.09.024.
Google Scholar | Crossref | Medline17. Nikko, AP, Dunningan, M, Cockerell, CJ. Calciphylaxis with histologic changes of pseudoxanthoma elasticum. Am J Dermatopathol. 1996;18(4):396-399.
Google Scholar | Crossref | Medline18. Mochel, MC, Arakaki, RY, Wang, G, Kroshinsky, D, Hoang, M. Cutaneous calciphylaxis: a retrospective histopathologic evaluation. Am J Dermatopathol. 2013;35(5):582-6. doi:10.1097/DAD.0b013e31827c7f5d.
Google Scholar | Crossref | Medline19. Au, S, Crawford, RI. Three-dimensional analysis of a calciphylaxis plaque: clues to pathogenesis. J Am Acad Dermatol. 2002;47(1):53-57.
Google Scholar | Crossref | Medline | ISI20. Bhambri, A, Del Rosso, JQ. Calciphylaxis: a review. J Clin Aesthet Dermatol. 2008;1(2):38.
Google Scholar | Medline21. Brandenburg, VM, Sinha, S, Torregrosa, JV, et al. Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis. J Nephrol. 2019;32(5):811-821. doi:10.1007/s40620-019-00631-0.
Google Scholar | Crossref | Medline22. Barreto, FC, Barreto, DV, Moysés, RM, et al. KDOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients. Kidney Int. 2008;73(6):771-777. doi:10.1038/sj.ki.5002769.
Google Scholar | Crossref | Medline | ISI23. Floege, J, Kubo, Y, Floege, A, Chertow, GM, Parfrey, PS. The effect of cinacalcet on calcific uremic arteriolopathy events in patients receiving hemodialysis: the EVOLVE trial. Clin J Am Soc Nephrol. 2015;10(5):800-807.
Google Scholar | Crossref | Medline24. McCarthy, JT, El-Azhary, RA, Patzelt, MT, et al. Survival, risk factors, and effect of treatment in 101 patients with calciphylaxis. Mayo Clin Proc. 2016; 91:1384-1394.
Google Scholar | Crossref | Medline25. Harris, C, Kiaii, M, Lau, W, Farah, M. Multi-intervention management of calcific uremic arteriolopathy in 24 patients. Clin Kidney J. 2018 Oct;11(5):704-709. doi:10.1093/ckj/sfy007.
Google Scholar | Crossref | Medline26. Weening, RH, Sewell, LD, Davis, MDP, McCarthy, JT, Pittelkow, MR. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol. 2007;56(4):569-579.
Google Scholar | Crossref | Medline27. Sato, T, Ichioka, S. How should we manage multiple skin ulcers associated with calciphylaxis? J Dermatol. 2012;39(11):966-968. doi:10.1111/j.1346-8138.2012.01510. x.
Google Scholar | Crossref | Medline28. Picazo, M, Bover, J, de la Fuente, J, Sans, R, Cuxart, M, Matas, M. Sterile maggots like coadjuvanted at the local treatment in a patient with proximal calciphylaxis. Nefrologia. 2005;25:559-562.
Google Scholar | Medline29. Polizzotto, MN, Bryan, T, Ashby, MA, Martin, P. Symptomatic management of calciphylaxis: a case series and review of the literature. J Pain Symptom Manage. 2006;32:186-190.
Google Scholar | Crossref | Medline30. Basile, C, Montanaro, A, Masi, M, Pati, G, De Maio, P, Gismondi, A. Hyperbaric oxygen therapy for calcific uremic arteriolopathy: a case series. J Nephrol. 2002;15:676-680.
Google Scholar | Medline | ISI31. Nigwekar, SU, Brunelli, SM, Meade, D, Wang, W, Hymes, J, Lacson, E Sodium thiosulfate therapy for calcific uremic arteriolopathy. Clin J Am Soc Nephrol. 2013;8:1162-1170.
Google Scholar | Crossref | Medline | ISI32. Nigwekar, S, Thadani, R. Calciphylaxis. In Melin, JA ed., UpToDate. https://www.uptodate.com/contents/calciphylaxis-calcific-uremic-arteriolopathy. Published 2021. Accessed November 10, 2021
Google Scholar33. Strazzula, L, Nigwekar, SU, Steele, D, et al. Intralesional sodium thiosulfate for the treatment of calciphylaxis. JAMA Dermatol. 2013;149(8):946-949. doi:10.1001/jamadermatol.2013.4565.
Google Scholar | Crossref | Medline34. Gupta, DR, Sangha, H, Khanna, R. Chemical peritonitis after intraperitoneal sodium thiosulfate. Perit Dial Int. 2012;32(2):220-222. doi:10.3747/pdi.2011.00088.
Google Scholar | SAGE Journals35. Torregrosa, JV, Sánchez-Escuredo, A, Barros, X, Blasco, M, Campistol, JM. Clinical management of calcific uremic arteriolopathy before and after therapeutic inclusion of bisphosphonates. Clin Nephrol. 2015;83:231-234.
Google Scholar | Medline36. Iwagami, M, Mochida, Y, Ishioka, K, et al. LDL-apheresis dramatically improves generalized calciphylaxis in a patient undergoing hemodialysis. Clin Nephrol. 2014;81(3):198-202. doi:10.5414/CN107482.
Google Scholar | Crossref | Medline37. Brandenburg, VM, Kramann, R, Rothe, H, et al. Calcific uremic arteriolopathy (calciphylaxis): data from a large nationwide registry. Nephrol Dial Transplant. 2017;32(1):126-132. doi:10.1093/ndt/gfv438.
Google Scholar | Crossref | Medline38. el-Azhary, RA, Arthur, AK, Davis, MD, et al. Retrospective analysis of tissue plasminogen activator as an adjuvant treatment for calciphylaxis. JAMA Dermatol. 2013;149(1):63-67. doi: 10.1001/2013.jamadermatol.5.
Google Scholar | Crossref | Medline39. Udomkarnjananun, S, Kongnatthasate, K, Praditpornsilpa, K, et al. Treatment of calciphylaxis in CKD: a systematic review and meta-analysis. Kidney Int Rep. 2019;4(2):231-244.
Google Scholar | Crossref | Medline40. Nigwekar, SU. Calciphylaxis. Curr Opin Nephrol Hypertens. 2017;26(4):276-281.
Google Scholar | Crossref | Medline